I think they’re saying the results can’t be used to determine disease progression and can’t be used as a basis to move to Phase 2. The following sentence says:
”PharmAust intends to continue with MPL dose escalation for Cohorts 3 and 4 to determine the optimum dosage for Phase 2.”
Clearly saying more work needs to be done before moving to Phase 2.
I do think it’s poorly worded for a layman to easily understand.
- Forums
- ASX - By Stock
- PAA
- Ann: Results show MPL suppresses biomarkers associated with MND
Ann: Results show MPL suppresses biomarkers associated with MND, page-117
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $87.51M |
Open | High | Low | Value | Volume |
17.0¢ | 18.0¢ | 16.8¢ | $145.2K | 842.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43015 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 318417 | 0.170 |
7 | 337468 | 0.165 |
7 | 198000 | 0.160 |
4 | 512800 | 0.155 |
8 | 328999 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 371375 | 7 |
0.185 | 177426 | 2 |
0.190 | 261458 | 4 |
0.195 | 233327 | 5 |
0.200 | 1065496 | 12 |
Last trade - 15.59pm 16/08/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |